Pfizer, the manufacturer of antidepressant Effexor XR (extended-release venlafaxine) capsules has issued a voluntary recall of two lots of 150 mg Effexor XR capsules and one lot of Greenstone-branded generic 150 mg venlafaxine ER capsules.
There has been a report from a pharmacist that one bottle of Effexor XR contained a capsule of a different medication, Tikosyn (dofetilide), in addition to the Effexor XR capsules. The recall includes the lot that bottle was from, and the others packaged on the same line as a precaution.
Tikosyn is an antiarrhythmic used to treat irregular heartbeats, and may cause serious side effects. It’s unlikely that any other packages of Effexor XR will contain Tikosyn capsules, but if you believe you’ve taken one by mistake, contact your healthcare provider or hospital immediately.
The recalled Pfizer lots are V130142 and V130140, and the recalled generic Greenstone lot is V130014. The Pfizer lots expire in October 2015, and the Greenstone lot expires in August 2015. You can see packaging and pill images of the affected products here.
This recall is at the patient level, so if you believe you have Effexor XR or extended-release venlafaxine from one of the affected lots, notify your doctor and/or return your prescription to your pharmacy. If you have any questions about returning the product, you can call 1-888-345-0481 for more information.
You can also contact Pfizer at 1-800-438-1985 with questions regarding the recall, and find more information in the full FDA announcement here.